No results were found for your search. Please adjust your search term or broaden your search criteria.
Still can't find what you are looking for? We can prepare Custom Research for you.
CAR Immunotherapeutic is a type of cancer immunotherapy that uses genetically modified T cells to target and destroy cancer cells. It is a form of adoptive cell transfer therapy, which involves extracting T cells from a patient, genetically engineering them to recognize and attack cancer cells, and then reintroducing them into the patient's body. CAR Immunotherapeutic has been used to treat a variety of cancers, including leukemia, lymphoma, and multiple myeloma.
CAR Immunotherapeutic has been shown to be effective in treating cancer, with some studies showing complete remission in some patients. It is also associated with fewer side effects than traditional chemotherapy and radiation treatments.
CAR Immunotherapeutic is a rapidly growing field, with many companies developing and marketing products. Some of these companies include Novartis, Kite Pharma, Juno Therapeutics, and Bluebird Bio. Show Less Read more
